484 related articles for article (PubMed ID: 23443556)
21. The effect of LXRα, ChREBP and Elovl6 in liver and white adipose tissue on medium- and long-chain fatty acid diet-induced insulin resistance.
Sun H; Jiang T; Wang S; He B; Zhang Y; Piao D; Yu C; Wu N; Han P
Diabetes Res Clin Pract; 2013 Dec; 102(3):183-92. PubMed ID: 24262945
[TBL] [Abstract][Full Text] [Related]
22. The Roles of Carbohydrate Response Element Binding Protein in the Relationship between Carbohydrate Intake and Diseases.
Iizuka K
Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769488
[TBL] [Abstract][Full Text] [Related]
23. Pentoxifylline aggravates fatty liver in obese and diabetic ob/ob mice by increasing intestinal glucose absorption and activating hepatic lipogenesis.
Massart J; Robin MA; Noury F; Fautrel A; Lettéron P; Bado A; Eliat PA; Fromenty B
Br J Pharmacol; 2012 Mar; 165(5):1361-74. PubMed ID: 21740407
[TBL] [Abstract][Full Text] [Related]
24. ChREBP: a glucose-activated transcription factor involved in the development of metabolic syndrome.
Iizuka K; Horikawa Y
Endocr J; 2008 Aug; 55(4):617-24. PubMed ID: 18490833
[TBL] [Abstract][Full Text] [Related]
25. Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice.
Dentin R; Benhamed F; Hainault I; Fauveau V; Foufelle F; Dyck JR; Girard J; Postic C
Diabetes; 2006 Aug; 55(8):2159-70. PubMed ID: 16873678
[TBL] [Abstract][Full Text] [Related]
26. Human hepatic lipase overexpression in mice induces hepatic steatosis and obesity through promoting hepatic lipogenesis and white adipose tissue lipolysis and fatty acid uptake.
Cedó L; Santos D; Roglans N; Julve J; Pallarès V; Rivas-Urbina A; Llorente-Cortes V; Laguna JC; Blanco-Vaca F; Escolà-Gil JC
PLoS One; 2017; 12(12):e0189834. PubMed ID: 29244870
[TBL] [Abstract][Full Text] [Related]
27. A Role of the Inflammasome in the Low Storage Capacity of the Abdominal Subcutaneous Adipose Tissue in Obese Adolescents.
Kursawe R; Dixit VD; Scherer PE; Santoro N; Narayan D; Gordillo R; Giannini C; Lopez X; Pierpont B; Nouws J; Shulman GI; Caprio S
Diabetes; 2016 Mar; 65(3):610-8. PubMed ID: 26718495
[TBL] [Abstract][Full Text] [Related]
28. Targeting hepatic pyruvate dehydrogenase kinases restores insulin signaling and mitigates ChREBP-mediated lipogenesis in diet-induced obese mice.
Wu CY; Tso SC; Chuang JL; Gui WJ; Lou M; Sharma G; Khemtong C; Qi X; Wynn RM; Chuang DT
Mol Metab; 2018 Jun; 12():12-24. PubMed ID: 29656110
[TBL] [Abstract][Full Text] [Related]
29. [The transcription factor ChREBP: a key modulator of insulin sensitivity?].
Benhamed F; Poupeau A; Postic C
Med Sci (Paris); 2013; 29(8-9):765-71. PubMed ID: 24005632
[TBL] [Abstract][Full Text] [Related]
30. A critical role for ChREBP-mediated FGF21 secretion in hepatic fructose metabolism.
Fisher FM; Kim M; Doridot L; Cunniff JC; Parker TS; Levine DM; Hellerstein MK; Hudgins LC; Maratos-Flier E; Herman MA
Mol Metab; 2017 Jan; 6(1):14-21. PubMed ID: 28123933
[TBL] [Abstract][Full Text] [Related]
31. Hepatic stearoyl CoA desaturase 1 deficiency increases glucose uptake in adipose tissue partially through the PGC-1α-FGF21 axis in mice.
Aljohani A; Khan MI; Bonneville A; Guo C; Jeffery J; O'Neill L; Syed DN; Lewis SA; Burhans M; Mukhtar H; Ntambi JM
J Biol Chem; 2019 Dec; 294(51):19475-19485. PubMed ID: 31690632
[TBL] [Abstract][Full Text] [Related]
32. Aberrant hepatic expression of PPARgamma2 stimulates hepatic lipogenesis in a mouse model of obesity, insulin resistance, dyslipidemia, and hepatic steatosis.
Zhang YL; Hernandez-Ono A; Siri P; Weisberg S; Conlon D; Graham MJ; Crooke RM; Huang LS; Ginsberg HN
J Biol Chem; 2006 Dec; 281(49):37603-15. PubMed ID: 16971390
[TBL] [Abstract][Full Text] [Related]
33. ChREBP-Mediated Regulation of Lipid Metabolism: Involvement of the Gut Microbiota, Liver, and Adipose Tissue.
Iizuka K; Takao K; Yabe D
Front Endocrinol (Lausanne); 2020; 11():587189. PubMed ID: 33343508
[TBL] [Abstract][Full Text] [Related]
34. Regulation and Metabolic Significance of
Song Z; Xiaoli AM; Yang F
Nutrients; 2018 Sep; 10(10):. PubMed ID: 30274245
[No Abstract] [Full Text] [Related]
35. Absence of Carbohydrate Response Element Binding Protein in Adipocytes Causes Systemic Insulin Resistance and Impairs Glucose Transport.
Vijayakumar A; Aryal P; Wen J; Syed I; Vazirani RP; Moraes-Vieira PM; Camporez JP; Gallop MR; Perry RJ; Peroni OD; Shulman GI; Saghatelian A; McGraw TE; Kahn BB
Cell Rep; 2017 Oct; 21(4):1021-1035. PubMed ID: 29069585
[TBL] [Abstract][Full Text] [Related]
36. HCF-1 Regulates De Novo Lipogenesis through a Nutrient-Sensitive Complex with ChREBP.
Lane EA; Choi DW; Garcia-Haro L; Levine ZG; Tedoldi M; Walker S; Danial NN
Mol Cell; 2019 Jul; 75(2):357-371.e7. PubMed ID: 31227231
[TBL] [Abstract][Full Text] [Related]
37. Pu'erh tea extract-mediated protection against hepatosteatosis and insulin resistance in mice with diet-induced obesity is associated with the induction of de novo lipogenesis in visceral adipose tissue.
Cai X; Hayashi S; Fang C; Hao S; Wang X; Nishiguchi S; Tsutsui H; Sheng J
J Gastroenterol; 2017 Dec; 52(12):1240-1251. PubMed ID: 28364190
[TBL] [Abstract][Full Text] [Related]
38. Reduced Nogo expression inhibits diet-induced metabolic disorders by regulating ChREBP and insulin activity.
Zhang S; Guo F; Yu M; Yang X; Yao Z; Li Q; Wei Z; Feng K; Zeng P; Zhao D; Li X; Zhu Y; Miao QR; Iwakiri Y; Chen Y; Han J; Duan Y
J Hepatol; 2020 Dec; 73(6):1482-1495. PubMed ID: 32738448
[TBL] [Abstract][Full Text] [Related]
39. Comparison of the expression and activity of the lipogenic pathway in human and rat adipose tissue.
Letexier D; Pinteur C; Large V; Fréring V; Beylot M
J Lipid Res; 2003 Nov; 44(11):2127-34. PubMed ID: 12897191
[TBL] [Abstract][Full Text] [Related]
40. Recent progress on the role of ChREBP in glucose and lipid metabolism.
Iizuka K
Endocr J; 2013; 60(5):543-55. PubMed ID: 23604004
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
